On the mode of action of thrombin-induced angiogenesis: Thrombin peptide, TP508, mediates effects in endothelial cells via α vβ3 integrin

Thrombosis and Haemostasis

Volumn 92, Issue 4, 2004, Pages 846-857

  Tsopanoglou, Nikos E ^a   Papaconstantinou, Matthew E ^a   Flordellis, Christodoulos S ^a   Maragoudakis, Michael E ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

v 3 integrin; RGD; Thrombin; TP508

Indexed keywords

ALANINE; AMINO ACID; ARGININE; ARGINYLGLYCYLASPARTIC ACID; ASPARTIC ACID; CILENGITIDE; CYCLOPEPTIDE; EMD 135981; FOCAL ADHESION KINASE; GELATINASE A; INTEGRIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROSTACYCLIN; PROSTACYCLIN DERIVATIVE; SYNTHETIC PEPTIDE; THROMBIN; THROMBIN DERIVATIVE; THROMBIN RECEPTOR ACTIVATING PEPTIDE; TP 508; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR; VITRONECTIN RECEPTOR;

AMINO ACID SEQUENCE; ANGIOGENESIS; ARTICLE; CATALYSIS; CELL ADHESION; CELL MIGRATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROTEIN EXPRESSION; PROTEIN IMMOBILIZATION; SIGNAL TRANSDUCTION; UPREGULATION;

CELL ADHESION; CELL MOVEMENT; ENDOTHELIUM, VASCULAR; HUMANS; INTEGRINS; MAP KINASE SIGNALING SYSTEM; NEOVASCULARIZATION, PHYSIOLOGIC; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; RECEPTORS, VITRONECTIN; THROMBIN; UMBILICAL VEINS;

EID: 6344257143     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH04-04-0208     Document Type: Article

References (39)

1. Macfarlane SR, Seatter MJ, Kanke T, et al. Proteinase-activated receptors. Pharmacol Rev 2001; 53: 245-82.
2. Rickles FR, Patierno S, Fernandez PM. Tissue factor, thrombin and cancer. Chest 2003; 124: 58S-68S, 2003.
3. Tsopanoglou NE, Pipili-Synetos E, Maragoudakis ME. Thrombin promotes angiogenesis by a mechanism independent of fibrin formation. Am J Physiol Cell Physiol 1993; 264: C1302-C1307.
4. Griffin CT, Srinivasan Y, Zheng YW, et al. A role for thrombin receptor signaling in endothelial cells during embryonic development. Science 2001; 293: 1666-70.
5. Tsopanoglou NE, Maragoudakis ME. On the mechanism of thrombin-induced angiogenesis. Potentiation of vascular endothelial growth factor activity on endothelial cells by up-regulation of its receptors. J Biol Chem 1999; 274: 23969-76.
6. Mohle R, Green D, Moore MA, et al. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc Natl Acad Sci USA 1997; 94: 663-9.
7. Huang YQ, Li JJ, Hu L, et al. Thrombin induces increased expression and secretion of VEGF in human FS4 fibroblasts, DU145 prostate cells and CHRF megakaryocytes. Thromb Haemost 2001; 86: 1094-8.
8. Huang YQ, Li JJ, Hu L, et al. Thrombin induces increased expression and secretion of angiopoietin-2 from human umbilical vein endothelial cells. Blood 2002; 99: 1646-50.
9. Tsopanoglou NE, Maragoudakis ME. On the mechanism of thrombin-induced angiogenesis: inhibition of attachment of endothelial cells on basement membrane proteins. Angiogenesis 1998; 1: 192-200.
10. 3 integrin. Am J Physiol Cell Physiol 2002; 283: C1501-C1510.
11. Zucker S, Conner C, DiMassmo BI, et al. Thrombin induces the activation of progelatinase A in vascular endothelial cells. J Biol Chem 1995; 270: 23730-8.
12. 3. Cell 1996; 85: 683-93.
13. Stiernberg J, Norfleet AM, Redin WR, et al. Acceleration of full-thickness would healing in normal rats by the synthetic thrombin peptide, TP508. Wound Rep Reg 2000; 8: 204-15.
14. Norfleet AM, Huang Y, Sower LE, et al. Thrombin peptide TP508 accelerates closure of dermal excisions in animal tissue with surgically induced ischemia. Wound Rep Reg 2000; 8: 517-29.
15. Dechantsreiter MA, Planker E, Matha B, et al. N-methylated cyclic RGD as highly active and selective alpha (V) beta 3 integrin antagonists. J Med Chem 1999; 42: 3033-40.
16. Hewett PW, Murray JC. Coexpression of flt-1, flt-4 and KDR in freshly isolated and cultured human endothelial cells. Bioch Biophys Res Commun 1996; 221: 697-702.
17. Maragoudakis ME, Kraniti N, Giannopoulou E, et al. Modulation of angiogenesis and progelatinase B by thrombin receptor mimetics and antagonists. Endothelium 2001; 8: 195-205.
18. Qi M, Ikematsu S, Maeda N, et al. Haptotactic migration induced by midkine. Involvement of protein-tyrosine phosphatase zeta. Mitogen-activated protein kinase and phosphotidylinositol 3-kinase. J Biol Chem 2001; 276: 15868-75.
19. Giancotti FG. Complexity and specificity of integrin signaling. Nat Cell Biol 2000; 2: E13-E14.
20. v integrin during angiogenesis: insights into potential mechanisms of action and clinical development. J Clin Invest 1999; 103: 1227-30.
21. 2 release but has no effect on von Willebrand factor secretion or E-selectin expression. FEBS Let 1996; 388: 180-4.
22. Coughlin SR. Thrombin signaling and protease-activated receptors. Nature 2000; 407: 258-64.
23. Glenn KC, Frost GH, Bergmann S, et al. Synthetic peptides bind to high-affinity thrombin receptors and modulate thrombin mitogenesis. Peptide Res 1988; 1: 65-73.
24. Carney DH, Mann R, Redin WR, et al. Enhancement of incisional wound healing and neovascularization in normal rats by thrombin and synthetic thrombin receptor-activating peptides. J Clin Invest 1992; 89: 1469-77.
25. Sower LE, Payne DA, Meyers R, et al. Thrombin peptide, TP508, induces differential gene expression in fibroblasts a nonproteolytic activation pathway. Exp Cell Res 1999; 247: 422-31.
26. Abedi H, Zachary I. Vascular endothelial growth factor stimulates tyrosine phosphorylation and recruitment to new focal adhesions of focal adhesion kinase and paxillin in endothelial cells. J Biol Chem 1997; 272: 15442-51.
27. Bar-Shavit R., Eldor B, Vlodavsky I. Binding of thrombin to subendothelial extracellular matrix: protection and expession of functional properties. J Clin Invest 1989; 84: 1096-104.
28. Wilner GD, Danitz MP, Mudd SM, et al. Selective immobilization of alpha-thrombin by surface-bound fibrin. J Lab Clin Med 1981; 97: 403-11.
29. Pepper MS. Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler Thromb Vasc Biol 2001; 21: 1104-17.
30. Thompson WD, Smith E, Stirk CM, et al. Angiogenic activity of fibrin degratation products is located in fibrin fragment E. J Pathol 1992; 168: 47-53.
31. Bootle-Wilbraham CA, Tazzyman S, Marshall JM, et al. Fibrinogen E-fragment inhibits the migration and tubule formation of human dermal microvascular endothelial cells in vitro. Cancer Res 2000; 60: 4719-24.
32. Bar-Shavit, R., Eskohjido, Y., Fenton II, J.W, et al. Thrombin adhesive properties: induction by plasmin and heparan sulfate. J Cell Biol 1993; 123: 1279-87.
33. Stetler-Stevenson WG. Dynamics of matrix turnover during pathological remodeling of the extracellular matrix. Am J Pathol 1996; 48: 1345-50.
34. Seiffert D, Smith JW. The cell adhesion domain in plasma vitronectin is cryptic. J Biol Chem 1997; 272: 13705-10.
35. Languino RL, Plescia J, Duperray A, et al. Fibrinogen mediates leukocyte adhesion to vascular endothelium through an ICAM-1-dependent pathway. Cell 1993; 73: 1423-34.
36. 3 integrin antagonists inhibits thrombin-induced proliferation and focal adhesion formation in smooth muscle cells. Am J Physiol Cell Physiol 2003; 285: C1330-C1338.
37. 5 integrin. J Biol Chem 2001; 276: 10950-62.
38. 3 integrin binding sites on tumstatin regulate distinct anti-tumor properties. J Biol Chem 2000; 275: 23745-50.
39. Rehn M, Veikkola T, Kukk-Valdre E, et al. Interaction of endostatin with integrins implicated in angiogenesis. Proc Natl Acad Sci 2001; 98: 1024-9.